Novartis
NVS
NVS
1,176 hedge funds and large institutions have $21.5B invested in Novartis in 2020 Q4 according to their latest regulatory filings, with 145 funds opening new positions, 378 increasing their positions, 437 reducing their positions, and 70 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
5% more funds holding
Funds holding: 1,118 → 1,176 (+58)
0.07% more ownership
Funds ownership: 9.17% → 9.24% (+0.07%)
14% less repeat investments, than reductions
Existing positions increased: 378 | Existing positions reduced: 437
Holders
1,176
Holding in Top 10
14
Calls
$245M
Puts
$117M
Top Buyers
| 1 | +$908M | |
| 2 | +$161M | |
| 3 | +$60.2M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$50.1M |
| 5 |
Capital Research Global Investors
Los Angeles,
California
|
+$43M |
Top Sellers
| 1 | -$182M | |
| 2 | -$178M | |
| 3 | -$161M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$107M |
| 5 |
Primecap Management
Pasadena,
California
|
-$72.3M |